Beam Therapeutics (BEAM) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

23.150
-0.320-1.36%

Trading Apr 24 11:05 ET

1.91BMarket Cap-13459P/E (TTM)

Intraday

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Benign Growth For Beam Therapeutics Inc. (NASDAQ:BEAM) Underpins Stock's 30% Plummet
Beam Therapeutics Inc. (NASDAQ:BEAM) shareholders won't be pleased to see that the share price has had a very rough month, dropping 30% and undoing the prior period's positive performance. Instead
Simply Wall St08:51 ET
Expert Ratings For Beam Therapeutics
In the latest quarter, 5 analysts provided ratings for Beam Therapeutics (NASDAQ:BEAM), showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recent r
Benzinga14:00 ET
Express News | Wedbush Reiterates Outperform on Beam Therapeutics, Maintains $57 Price Target
Moomoo 24/712:32 ET
Beam Therapeutics: A Strong Buy on Gene Editing Advancements and Strategic Growth Potential
TipRanksApr 23 07:16 ET
Beam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene Editing
TipRanksApr 22 16:37 ET
Popular Crypto Trader Shares 2024 Predictions For These Three Altcoins
Popular pseudonymous crypto analyst Altcoin Sherpa on Friday shared his insights on three altcoins: Beam (CRYPTO: BEAM), Arbitrum (CRYPTO: ARB), and Render (CRYPTO: RNDR). BEAM: A Bullish Bet On Crypt
BenzingaApr 12 13:55 ET

Comments

PaulG

Feb 28 04:10

$Beam Therapeutics(BEAM.US)$ Will double to 90 dollars 💸 💵 💲

Kevin Travers

Feb 28 00:02

ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Dec 14, 2023 19:35

Beam Therapeutics' CEO, John Evans showed confidence in Ms. Shaw's ability to turn scientific innovations into commercial treatments. Shaw recognizes Beam's groundbreaking work in genetic medicine and gene editing, predicting major clinical milestones ahead thanks to the company's comprehensive platform and capabilities.

Press Release: Beam Therapeutics Appoints Biotech Executive Christi Shaw to Its Board of Directors

Chatterbox Moo

Nov 27, 2023 18:15

ColumnsGene Editing: Is This "Turning Point in Medicine" a Potential Source of Blockbuster Revenue?

The first treatment based on CRISPR technology is poised to win FDA approval next month, offering hope to patients and opportunities to investors.
"A turning point in medicine"
Scientists have made significant progress in treating thousands of illnesses over the years, but finding cures for rare and deadly diseases remains a significant challenge. While treatments for inherited conditions like sickle cell...

Moomoo AI

Nov 2, 2023 03:59

Analysts convey bullish views on the company's prospects, with reduced estimated losses and upgraded revenue estimates. However, issues like dilutive stock issuance hint at potential risks.